Clinical Diagnosis of the Olfactory Nerve Transport Function

DOI Web Site Web Site PubMed 22 References
  • Shiga Hideaki
    Department of Otorhinolaryngology-Head and Neck Surgery, Kanazawa Medical University
  • Yamamoto Junpei
    Department of Otorhinolaryngology-Head and Neck Surgery, Kanazawa Medical University
  • Miwa Takaki
    Department of Otorhinolaryngology-Head and Neck Surgery, Kanazawa Medical University

Bibliographic Information

Other Title
  • 嗅神経輸送機能の臨床診断
  • キュウシンケイ ユソウ キノウ ノ リンショウ シンダン

Search this article

Abstract

  Nasal administration of macromolecular drugs (peptides, nanoparticles) has a possibility to enable a drug delivery system beyond the blood brain barrier via olfactory nerve transport. Basic research on nasal drug delivery to the brain has been well studied. However, evaluation of the olfactory nerve transport function in patients with olfactory disorders has yet to be done, although such an evaluation is important in selecting candidates for clinical trials. Current olfactory function tests are useful for the analysis of olfactory thresholds in olfaction-impaired patients. However, the usefulness of using the increase in olfactory thresholds in patients as an index for evaluating olfactory nerve damage has not been confirmed because of the difficulty in directly evaluating the viability of the peripheral olfactory nerves. Nasally administered thallium-201 migrates to the olfactory bulb, as has been shown in healthy volunteers. Furthermore, transection of olfactory nerve fibers in mice significantly decreases migration of nasally administered thallium-201 to the olfactory bulb. The migration of thallium-201 to the olfactory bulb is reduced in patients with impaired olfaction due to head trauma, upper respiratory tract infections, and chronic rhinosinusitis, relative to the values in healthy volunteers. Nasally administrating thallium-201 followed by single photon emission computed tomography, X-ray computed tomography and magnetic resonance imaging might be useful in choosing candidates for clinical trials of nasal drug delivery methods to the brain.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 132 (11), 1263-1266, 2012-11-01

    The Pharmaceutical Society of Japan

References(22)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top